Home
Syde Platform
Clinical Research
Sysnav HealthCare
News & Events
Contact
SYSNAV Healthcare Announces EMA Primary Endpoint Qualification of Stride Velocity 95th Centile (SV95C) for Duchenne Muscular Dystrophy.
Learn More
Home
Syde Platform
Clinical Research
Sysnav HealthCare
News & Events
Contact
December 2022
ECTRIMS 2022
November 2022
SYSNAV sponsors the Angelman Syndrome Biomarkers & Outcome Measures Scientific Meeting
November 2022
SMA Europe – Oct 2022
October 2022
World Muscle Society 2022
October 2022
Study Results with SV95C real-world data – Solid Biosciences
July 2022
17th International Congress on Neuromuscular Diseases
This site uses cookies to guarantee you the best possible experience.
Accept
Decline